Alexander Chi MD is a highly trained, highly experienced physician working within the field of cancer research and treatment. He has worked in academic institutions such as West Virginia University treating patients and conducting translational cancer research. He has had an immense amount of experience in the field of thoracic radiotherapy, which treats cancer that develops within the upper aero-digestive track such as the lungs, and the esophagus. He specializes in an innovative and modern type of radiotherapy treatment called stereotactic ablative radiotherapy. He was the first physician to use this therapy method on a cancer patient at West Virginia University.

Alexander Chi MD uses a highly innovative radiotherapy treatment known as stereotactic ablative radiotherapy. This type of therapy is extremely modern and accurate as it pinpoints to the cancer directly within the patient's body without damaging the surrounding healthy tissue. Using smaller, thinner beams of radiation as opposed to other radiation technologies, stereotactic ablative radiotherapy maximizes the chance to destroy the cancer without having the patient suffer from unnecessary radiation damage. This type of therapy is typically used on patients with smaller non-small cell lung cancers or non-small cell lung cancer that have been noticed still within their early stages.

Alexander Chi MD has acquired an immense amount of experience over the years as a thoracic cancer research and treatment physician. This experience has allowed him to efficiently manage a team of healthcare professionals, including physicists, dosimetrists, nurses, and radiotherapists, to give each patient the best care available. He makes sure that each and every one of his patients is fully aware of the treatments that will be used, as well as the technology required to make them possible. This not only ensures the patient's knowledge of existing treatment options, but also makes them more comfortable throughout the course of their treatment.

Alexander Chi MD is a leader in the field of cancer treatment and research. His extensive experience and background in research and cancer treatment has given him a wealth of knowledge that he can use to treat his patients. Although his treatment method of choice is typically used only on patients who have caught their cancer within its early stages, he has had an extremely good track record treating his thoracic cancer patients.